Gas chromatography–mass spectrometry (GC–MS) and ion chromatography profile wasabi and mustard heat and acidity.
|Webcasts|December 10, 2020
The benefits of dedicated HPLC and chromatography column for analysis of Biomolecules
Author(s)Agilent Technologies, Inc.
***Live: North America: Thursday, December 10, 2020 11am EST | 8am PST Asia Pacific: Friday, December 11, 2020 8:30am IST | 12pm JST Europe: Friday, December 11, 2020 2pm GMT | 3pm CST***This webcast will showcase the challenges analytical laboratories face when analyzing biotherapeutics and how the hurdles of compromised sample integrity and surface interaction may be overcome with dedicated UHPLC instrumentation and chromatography columns.***On demand available after final airing until Jan. 11, 2020***
Register Free:
Event Overview: High performance liquid chromatography with optical detection or coupled to mass spectrometry are fundamental methods for characterization and quality control of biopharmaceutical products. Biotherapeutic molecules represent a versatile class of compounds that need special attention for sample preparation, LC instrumentation, and type of chromatography columns used. This webcast will showcase the challenges analytical laboratories face when analyzing biotherapeutics and how the hurdles of compromised sample integrity and surface interaction may be overcome.
Key Learning Objectives:
- In this webcast, we will present the basis for considerations of issues arising with biotherapeutic molecules with analytical instrumentation. Solutions will be shown for bio-inert and bio- compatible HPLC equipment, and how specific effects with bio-samples can be circumvented. Finally, we will highlight the benefits of chromatography column hardware and phases for selected application areas compared to classical stainless-steel column hardware.
Speakers: Cornelia Vad, Senior Product Manager Analytical HPLC, Agilent Technologies
Dr. Andrew Coffey, Senior Applications Chemist, Agilent Technologies
Times and Dates: North America: Thursday, December 10, 2020 11am EST | 8am PST
Asia Pacific: Friday, December 11, 2020 8:30am IST | 12pm JST
Europe: Friday, December 11, 2020 2pm GMT | 3pm CST
On Demand until Jan. 11, 2020.
Sponsor: Agilent
Register free:
Related to this article
How feasible is it to integrate this Bayesian graph-theory methodology into existing commercial chromatography software workflows for semi-automated data curation in routine analytical laboratories?
Reversed-phase high-performance liquid chromatography (RP-HPLC) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) show frequent milking alters cobra venom toxin makeup.
Gabriel Vivó-Truyols outlines the benefits and challenges of combining graph theory with Bayesian statistics to automate peak assignment and alignment.
This week, Chromatography Online’s coverage spanned lipidomics-based early cancer detection, career paths in separation science, machine learning and uncertainty-driven approaches to LC method development, new EU wastewater rules for pharmaceutical micropollutants, automated Separation Quality Factor (SQF) evaluation in chromatography data systems, and solutions to GLP-1 peptide analysis challenges.
Gabriel Vivó-Truyols from the Spanish Council for Scientific Research, Madrid, Spain. discusses his work on using graph theory and Bayesian statistics for peak assignment and chromatographic alignment.
Gas chromatography (GC) analysis ties prenatal mindfulness to shifts in placental fatty acids.
Gas chromatography–mass spectrometry (GC–MS) and liquid chromatography-quadrupole time-of-flight mass spectrometry (LC–qTOF–MS) reveal metabolic shifts in tricuspid regurgitation.
Trending on LCGC International
1
GLP-1 Peptide Analysis: Challenges and Solutions
2
HPLC–DAD Method Tracks Semaglutide and Tirzepatide Stability
3
Industry Roundup: Waters Posts Strong Third Quarter as LC–MS and Chromatography Consumables Drive Growth, Acquires Ion Mobility Pioneer MOBILion
4
LC–MS/MS Dried Blood Spot Test for Galactosemia
5